Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bhavsar EB"'
Autor:
Mato AR; Memorial Sloan Kettering Cancer Center, New York, New York. matoa@mskcc.org., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York., Jacobs R; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, North Carolina., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio., Lamanna N; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Brander D; Duke University Medical Center, Durham, North Carolina., Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Ujjani CS; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, Washington., Yazdy MS; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C., Perini GF; Hospital Israelita Albert Einstein, Sao Paulo, Pará, Brazil., Pinilla-Ibarz JA; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida., Barrientos J; North Shore University Hospital, Northwell Health, Manhasset, New York., Skarbnik AP; Novant Health, Charlotte, North Carolina., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Pu JJ; SUNY Upstate Medical University, Syracuse, New York., Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington., Gohil S; University College London, London, United Kingdom., Fakhri B; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California., Choi M; Moores Cancer Center, University of California San Diego, La Jolla, California., Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Rhodes J; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Barr PM; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, New York., Portell CA; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia., Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Garcia CA; Hillman Cancer Pavilion, Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Whitaker KJ; Memorial Sloan Kettering Cancer Center, New York, New York., Winter AM; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Sitlinger A; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Khajavian S; Fred Hutchinson Cancer Research Center, Seattle, Washington., Grajales-Cruz AF; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida., Isaac KM; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia., Shah P; Northwell Health, New York, New York., Akhtar OS; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Pocock R; University of College of London, London, United Kingdom., Lam K; Moores Cancer Center, University of California San Diego, La Jolla, California., Voorhees TJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Schuster SJ; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Rodgers TD; University of Rochester Medical Center, Rochester, New York., Fox CP; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Martinez-Calle N; Clinical Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham, England, United Kingdom., Munir T; Weill Cornell Medicine, Long Island City, New York., Bhavsar EB; Department of Haematology, St James's University Hospital, Leeds, United Kingdom., Bailey N; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington., Lee JC; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Weissbrot HB; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Nabhan C; Aptitude Health, Atlanta, Georgia., Goodfriend JM; Memorial Sloan Kettering Cancer Center, New York, New York., King AC; Clinical Pharmacy Specialist-Leukemia, Memorial Sloan Kettering Cancer Center, New York, New York., Zelenetz AD; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Dorsey C; Memorial Sloan Kettering Cancer Center, New York, New York., Bigelow K; Memorial Sloan Kettering Cancer Center, New York, New York., Cheson BD; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C., Allan JN; Department of Haematology, St James's University Hospital, Leeds, United Kingdom., Eyre TA; Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 15; Vol. 26 (14), pp. 3589-3596. Date of Electronic Publication: 2020 Mar 20.
Autor:
Mato AR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Roeker LE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Eyre TA; Cancer and Haematology Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom., Nabhan C; Aptitude Health, Chicago, IL., Lamanna N; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH., Brander DM; Department of Medicine, Duke University Cancer Center, Durham, NC., Barr PM; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY., Lansigan F; Department of Medicine, Norris Cotton Cancer Center, Dartmouth University, Lebanon, NH., Cheson BD; Department of Medicine, Lombardi Cancer Center, Georgetown University, Washington, DC., Singavi AK; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, WI., Yazdy MS; Department of Medicine, Lombardi Cancer Center, Georgetown University, Washington, DC., Shah NN; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, WI., Allan JN; Department of Hematology/Oncology, Weill Cornell Medical Center, New York, NY., Bhavsar EB; Department of Hematology/Oncology, Weill Cornell Medical Center, New York, NY., Rhodes J; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Kennard K; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Williams AM; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY., Skarbnik AP; Department of Medicine, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Goy AH; Department of Medicine, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Goodfriend JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Dorsey C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Coombs CC; Department of Medicine, University of North Carolina Cancer Center, Chapel Hill, NC., Tuncer H; Department of Medicine, Cancer Center, Tufts Medical Center, Boston, MA., Ujjani CS; Department of Medicine, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA., Jacobs R; Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC., Winter AM; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH., Pagel JM; Swedish Cancer Center, Seattle, WA., Bailey N; Swedish Cancer Center, Seattle, WA., Schuh A; Cancer and Haematology Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom., Shadman M; Department of Medicine, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA., Sitlinger A; Department of Medicine, Duke University Cancer Center, Durham, NC., Weissbrot H; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY., Muralikrishnan S; Department of Medicine, Norris Cotton Cancer Center, Dartmouth University, Lebanon, NH., Zelenetz A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom; and., Fox CP; Nottingham University Hospitals, NHS Foundation Trust, Nottingham, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2019 May 28; Vol. 3 (10), pp. 1568-1573.
Autor:
Gaiti F; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Chaligne R; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Gu H; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Brand RM; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Kothen-Hill S; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Schulman RC; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Grigorev K; Weill Cornell Medicine, New York, NY, USA., Risso D; Weill Cornell Medicine, New York, NY, USA.; Department of Statistical Sciences, University of Padova, Padova, Italy., Kim KT; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Pastore A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Huang KY; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Alonso A; Weill Cornell Medicine, New York, NY, USA., Sheridan C; Weill Cornell Medicine, New York, NY, USA., Omans ND; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Biederstedt E; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Clement K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wang L; Beckman Research Institute, City of Hope, Monrovia, CA, USA., Felsenfeld JA; Weill Cornell Medicine, New York, NY, USA., Bhavsar EB; Weill Cornell Medicine, New York, NY, USA., Aryee MJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Allan JN; Weill Cornell Medicine, New York, NY, USA., Furman R; Weill Cornell Medicine, New York, NY, USA., Gnirke A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu CJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Meissner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Max Planck Institute for Molecular Genetics, Berlin, Germany., Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.
Publikováno v:
Nature [Nature] 2019 May; Vol. 569 (7757), pp. 576-580. Date of Electronic Publication: 2019 May 15.
Autor:
Weidner AS; Department of Pathology and Laboratory Medicine †Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY., Panarelli NC, Geyer JT, Bhavsar EB, Furman RR, Leonard JP, Jessurun J, Yantiss RK
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2015 Dec; Vol. 39 (12), pp. 1661-7.
Autor:
Darman RB; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Seiler M; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Agrawal AA; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Lim KH; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Peng S; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Aird D; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Bailey SL; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Bhavsar EB; Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USA., Chan B; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Colla S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Corson L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Feala J; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Fekkes P; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Ichikawa K; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Keaney GF; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Lee L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Kumar P; Eisai, Inc., Andover, MA 01810, USA., Kunii K; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., MacKenzie C; Eisai, Inc., Andover, MA 01810, USA., Matijevic M; Eisai, Inc., Andover, MA 01810, USA., Mizui Y; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Myint K; Eisai, Inc., Andover, MA 01810, USA., Park ES; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Puyang X; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Selvaraj A; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Thomas MP; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Tsai J; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Wang JY; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Warmuth M; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Yang H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhu P; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Furman RR; Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USA., Yu L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Smith PG; H3 Biomedicine, Inc., Cambridge, MA 02139, USA., Buonamici S; H3 Biomedicine, Inc., Cambridge, MA 02139, USA. Electronic address: silvia_buonamici@h3biomedicine.com.
Publikováno v:
Cell reports [Cell Rep] 2015 Nov 03; Vol. 13 (5), pp. 1033-45. Date of Electronic Publication: 2015 Oct 22.